N/A N=63 Bystander Fatigue and CPR Quality Using Continuous Compressions Versus 30:2 Compressions to Ventilation
Cardiac Arrest
Primary: CPR Quality — 324.9; 381.5 Compressions
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=574 Best African American Response to Asthma Drugs
Asthma
Primary: The Primary Outcome is a Composite Measure That Uses Exacerbations, Asthma Control Days During the Last 12 of 14 Weeks of a Treatment Regimen, and Percent Predicted FEV1…
N/A N=50 Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants
Respiratory Distress Syndrome · Bronchopulmonary Dysplasia
Primary: Changes in the Measurements of Functional Residual Capacity (FRC) in Randomized Premature Infants — 12.6; 6.4; 27.2; 17.1 mL — p=<0.05
N/A N=38 Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose
Allergic Airway Disease
Primary: Total Nasal Cell Count in Response to DEP Challenge at 0, 6 and 24 hr With or Without BSE Intervention — 4.44; 4.50; 4.73; 4.70 log cells/mL — p=<0.001
Phase 2 N=37 Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndrome
Primary: Event Free Survival (EFS) at 1 Year — 26; 65 percentage of participants
N/A N=477 Evaluating Strategies to Present Colon Cancer Screening Information
Colonic Neoplasms · Colorectal Neoplasms · Colonic Diseases
Primary: Intentions to Get Screened for Colon Cancer — 68.64; 65.51; 64.30 units on a 0-100 scale — p=.362
Phase 3 N=252 Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115
Crohn's Disease
Primary: Percentage of Participants With Endoscopic Improvement at Week 40 in Participants With Endoscopic Improvement at Week 0 — 31.6 percentage of participants
Phase 3 N=409 A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)
Plaque Psoriasis
Primary: Percentage of Subjects Rated a "Treatment Success" Based on the Investigator's Global Assessment (IGA) — 30.7; 7.4 percentage of participants — p=<0.001
Phase 3 N=309 Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up
Actinic Keratosis
Primary: Complete Clearance of Actinic Keratosis (AK) — 20.4; 2.9 percentage of participants — p=0.001
N/A N=860 Barbershop Talk: HIV Prevention for African American Heterosexual Men
HIV
Primary: Sexual Behavior — 225; 163 Participants — p=0.04
N/A N=115 ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain
Bone Metastases · Multiple Myeloma
Primary: Number of Responders — 54; 6 Participants
Phase 3 N=917 A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy
Bowel Preparation
Primary: Percentage of Subjects Classified as a Responder Defined by "Excellent" or "Good" — 87.7; 81.5 Percentage of participants — p=0.0067
Phase 3 N=536 A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
Primary: Percentage of Participants With Major Molecular Response (MMR) at Month 12 — 47.2; 36.9 percentage of participants — p=0.0100
Phase 4 N=138 Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression
Depression
Primary: Hamilton Depression Rating Scale (HDRS) — 29.5; 30.4; 12.5; 11.1 units on a scale — p=<0.05
N/A N=264 The Houston HIITBAC for African Americans
Asthma
Primary: Change in Asthma Control Test (ACT) Score — 12.5; 12.5; 16.2; 16.8 score on a scale — p=0.575